Cargando…
PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer
Although endocrine therapy is the most important treatment option in estrogen receptor (ER)-positive breast cancer, new strategies, such as molecular targeted agents together with endocrine therapy are required to improve survival. PIK3CA is the most frequent mutated gene in ER-positive early breast...
Autores principales: | Ishida, Naoko, Baba, Motoi, Hatanaka, Yutaka, Hagio, Kanako, Okada, Hiromi, Hatanaka, Kanako C., Togashi, Kenichi, Matsuno, Yoshihiro, Yamashita, Hiroko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915150/ https://www.ncbi.nlm.nih.gov/pubmed/29707142 http://dx.doi.org/10.18632/oncotarget.24845 |
Ejemplares similares
-
Novel antibodies to phosphorylated α-synuclein serine 129 and NFL serine 473 demonstrate the close molecular homology of these epitopes
por: Rutherford, Nicola J., et al.
Publicado: (2016) -
Genetic heterogeneity during breast cancer progression in young patients
por: Hagio, Kanako, et al.
Publicado: (2021) -
Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre- and postmenopausal Japanese women
por: Guo, Jiazhi, et al.
Publicado: (2017) -
Evolutionary patterns of phosphorylated serines
por: Kurmangaliyev, Yerbol Z, et al.
Publicado: (2011) -
Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer
por: Yamashita, Hiroko, et al.
Publicado: (2005)